Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
REVENUE	$ 3,384,767	$ 1,417,725
Cost of Revenue	1,871,125	931,951
Gross profit	1,513,642	485,774
EXPENSES
General and administrative expenses [Notes 8, 9 and 10]	12,806,306	10,053,223
Research and development expenses	2,059,130	1,363,235
TOTAL OPERATING EXPENSES	14,865,436	11,416,458
Other income [Note 3]	(36,636)	(16,939)
Loss upon convertible promissory notes conversion [Note 8]	103,735
Accretion and amortization expenses [Note 5 and 7]	2,481,155	92,416
Change in fair value of derivative liabilities [Note 7]	(408,872)	60,781
NET LOSS BEFORE INCOME TAXES	(15,491,176)	(11,066,942)
Income taxes
NET LOSS BEFORE DIVIDENDS	(15,491,176)	(11,066,942)
Less: Preferred Stock Dividends	962,148	257,928
NET LOSS ATTRIBUTABLE TO COMMON STOCKLHOLDERS	(16,453,324)	(11,324,870)
Translation adjustment	223,121	(102,344)
COMPREHENSIVE LOSS	$ (162,330,203)	$ (11,427,214)
LOSS PER SHARE, BASIC AND DILUTED	$ (0.438)	$ (0.315)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	37,522,978	35,956,180